Related Experiment Video
Updated: Sep 9, 2025

07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.8K
The ASH Research Collaborative Sickle Cell Disease Research Network: past, present, and future
Fuad El Rassi1, Biree Andemariam2, Abdullah Kutlar3
1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
Blood Advances
|September 3, 2025
Summary
The American Society of Hematology
Area of Science:
- Hematology
- Clinical Research
- Public Health
Background:
- Sickle Cell Disease (SCD) historically received less research attention than other blood disorders.
- SCD significantly reduces life expectancy, necessitating urgent advancements in care and research.
- The American Society of Hematology (ASH) initiated a network to address these challenges.
Purpose of the Study:
- To introduce the ASH Research Collaborative Sickle Cell Disease Research Network.
- To outline the network's structure, including cooperative sites and a Data Hub.
- To present initial demographic data and the network's mission for transforming SCD care.
Main Methods:
- Establishment of a national research network with cooperative sites.
- Development of a Data Hub for aggregating real-world SCD data.
- Inclusion of Community Advisory Boards to guide research priorities.
Main Results:
- The network includes multiple research sites and a central data repository.
- Initial demographic data on patient records, encounters, lab data, and comorbidities are presented.
- The network facilitates comprehensive data collection for enhanced clinical insights.
Conclusions:
- The ASH Research Collaborative Sickle Cell Disease Research Network represents a significant initiative to advance SCD research.
- This coordinated effort aims to improve clinical insights and streamline research for better patient outcomes.
- The network's structure and data-driven approach promise to transform the landscape of SCD care.
Related Concept Videos
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Bone Marrow Sampling and Transplants
493
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
493
Multiple Allele Traits
34.8K
The Concept of Multiple Allelism
34.8K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57

